To require the Food and Drug Administration to revoke the approval of one opioid pain medication for each new opioid pain medication approved.
Summary
What This Bill Does
The bill requires findings Congress finds as follows: Drug overdoses killed more than 107,000 people in the United States in 2021 and requires requirement to revoke approval Notwithstanding any other provision of law, if the Secretary of Health and Human Services (referred to in this section as the Secretary) approves an application under subsection. It relies on reporting requirements and compliance mandates. The main policy areas are Healthcare Consumers, Healthcare, and Housing.
Who Benefits and How
Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Patients and health care consumers affected by the bill would take on compliance duties, and Homeowners, tenants, or housing market participants affected by the bill would take on compliance duties.
Key Provisions
- Requires findings Congress finds as follows: Drug overdoses killed more than 107,000 people in the United States in 2021.
- Requires requirement to revoke approval Notwithstanding any other provision of law, if the Secretary of Health and Human Services (referred to in this section as the Secretary) approves an application under subsection...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill requires findings Congress finds as follows: Drug overdoses killed more than 107,000 people in the United States in 2021 and requires requirement to revoke approval Notwithstanding any other provision of law, if the Secretary of Health and Human Services (referred to in this section as the Secretary) approves an application under subsection.
Key Policy Areas
Healthcare Consumers, Healthcare, Housing
Primary Purpose
The bill requires findings Congress finds as follows: Drug overdoses killed more than 107,000 people in the United States in 2021 and requires requirement to revoke approval Notwithstanding any other provision of law, if the Secretary of Health and Human Services (referred to in this section as the Secretary) approves an application under subsection.
Policy Domains
Whole bill
Identified Gains
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
Sponsors
Legislative Progress
IntroducedMr. Manchin (for himself and Mr. Braun) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology